AND EXCHANGE COMMISSION
to Section 13 or 15(d) of the Securities Exchange Act of 1934
of Report (Date of earliest event reported): October 12, 2017
INNOVATION HOLDINGS, INC.
name of registrant as specified in its charter)
or Other Jurisdiction
State Bridge Road, Suite G-328, Duluth, Georgia 30097
of Principal Executive Offices) (Zip Code)
telephone number, including area code)
name or former address, if changed since last report)
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
7 — REGULATION FD DISCLOSURE
7.01 Regulation FD Disclosure.
information in this Item 7.01 of this Current Report is furnished pursuant to Item 7.01 and shall not be deemed “filed”
for any purpose, including for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that
Section. The information in this Current Report on Form 8-K shall not be deemed incorporated by reference into any filing under
the Securities Act or the Exchange Act regardless of any general incorporation language in such filing.
October 12, 2017 Medical Innovation Holdings Inc. issued a press release. The text of the press release in its entirety is
attached herewith as Exhibit 99.1.
8 — OTHER EVENTS
8.01 Other Events
September 28, 2017, the Company retained Hart & Hart, LLC, of Denver, Colorado, as the Company’s corporate and securities
9 — FINANCIAL STATEMENTS AND EXHIBITS
9.01 Financial Statements and Exhibits.
following is a complete list of exhibits filed as part of this Report.
numbers correspond to the numbers in the exhibit table of Item 601 of Regulation S-K.
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
Innovation Holdings, Inc.|
Arturo Jake Sanchez|
Arturo “Jake” Sanchez
October 12, 2017